TNF Pharmaceuticals, formerly MyMD Pharmaceuticals, is a clinical stage biopharma company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases. Their lead clinical candidate, MYMD-1® is an orally available, next-generation TNF-alpha inhibitor with the potential to transform the way TNF-alpha based diseases are treated.
Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world.
Ayala is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
Ayala is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
McKesson is a leading healthcare company for wholesale medical supplies & equipment, pharmaceutical distribution, and healthcare technology solutions.
McKesson is a leading healthcare company for wholesale medical supplies & equipment, pharmaceutical distribution, and healthcare technology solutions.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with leading industry partners.
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
SymBio Pharma USA is the US subsidiary of SymBio Pharmaceuticals Limited, a pharmaceutical company with headquarters in Tokyo, Japan.
Eyconis, an Ascendis Pharma company, was created to develop, manufacture, and commercialize TransCon ophthalmology assets globally.
IFM Therapeutics, a Novartis company, is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
Fusion Pharmaceuticals, an AstraZeneca company, is a clinical-stage oncology company focused on developing next-generation RCs.
Fusion Pharmaceuticals, an AstraZeneca company, is a clinical-stage oncology company focused on developing next-generation RCs.
Terns Pharmaceuticals is an emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases.
MassBiologics, a division of the University of Massachusetts Medical School, develops and manufactures vaccines and other biologic products.
Ventoux Biosciences is a privately held pharmaceutical company focused on acquiring, in-licensing, developing, and commercializing proprietary products for Dupuytrenﾒs Disease, Ledderhose Disease, and related fibroproliferative, inflammatory conditions with significant unmet medical need.
Haleon is global consumer healthcare business created from a series of progressive strategic moves to develop the GSK Consumer Healthcare business.
Genus Lifesciences is a manufacturer of branded and generic pharmaceutical products.
Genus Lifesciences is a manufacturer of branded and generic pharmaceutical products.
Kyowa Kirin applies cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology.
Zambon is a pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives.
Zambon is a pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives.
Cipla, formerly InvaGen, is a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients.